Exenatide improves glucocorticoid-induced glucose intolerance in mice

Exenatide is an incretin mimetic that is recently available in the US for the treatment of diabetes. There is a paucity of information on the effects of exenatide in glucocorticoid (GC)-induced diabetes. Although the effect of continuous intravenous infusion of exenatide on GC-induced glucose intole...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ruiying, Fuentes-Mattei, Enrique, Velazquez-Torres, Guermarie, Su, Chun-Hui, Chen, Jian, Lee, Mong-Hong, Yeung, Sai-Ching Jim
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064408/
https://www.ncbi.nlm.nih.gov/pubmed/21448323
http://dx.doi.org/10.2147/DMSO.S15510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064408/
https://www.ncbi.nlm.nih.gov/pubmed/21448323
http://dx.doi.org/10.2147/DMSO.S15510

Ejemplares similares